There were 318 press releases posted in the last 24 hours and 437,673 in the last 365 days.

Contact

Please use this form to send email to PR contact of this press release:
Catalyst Biosciences Announces Acceleration of Phase 1/2 Trial of CB 2679d/ISU304 in Individuals with Hemophilia B

TO:



FROM:

Please check your email address!

Please, do not fill this field.

Please, do not change this field.

Please, do not fill if your javascript is turned off.

captcha image